CN206424205U - Lai Mushi pipe holders are applied with traction push function - Google Patents
Lai Mushi pipe holders are applied with traction push function Download PDFInfo
- Publication number
- CN206424205U CN206424205U CN201621076277.3U CN201621076277U CN206424205U CN 206424205 U CN206424205 U CN 206424205U CN 201621076277 U CN201621076277 U CN 201621076277U CN 206424205 U CN206424205 U CN 206424205U
- Authority
- CN
- China
- Prior art keywords
- chamber
- conduit
- lai mushi
- rack body
- push function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001149930 Protura <class> Species 0.000 claims abstract description 18
- 238000002347 injection Methods 0.000 claims abstract description 12
- 239000007924 injection Substances 0.000 claims abstract description 12
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- 210000003734 kidney Anatomy 0.000 claims description 4
- 239000011247 coating layer Substances 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229940021171 curative drug Drugs 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 8
- 208000010412 Glaucoma Diseases 0.000 abstract description 7
- 230000004410 intraocular pressure Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 description 7
- 210000001742 aqueous humor Anatomy 0.000 description 6
- 238000002513 implantation Methods 0.000 description 4
- 201000004569 Blindness Diseases 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 101100008048 Caenorhabditis elegans cut-4 gene Proteins 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Abstract
It is a kind of to apply Lai Mushi pipe holders with traction push function, belong to operated eye support technology field, the pusher being connected including rack body, with rack body, rack body is two-chamber tubular structure, two-chamber includes big chamber and small chamber, and big chamber is provided with waist hole with small chamber contact surface, and big chamber upper end is provided with the gap for traversing head and the tail, the two side of big chamber gap is provided with otch, and small chamber end end has a cone mouth；Pusher includes conduit, seal wire and injection device, and conduit includes proximal part and distal portions, and proximal part connects injection device, and the port of distal portions is conehead formula opening shape, and conehead formula opening shape and the small chamber end cone mouth of distal end of catheter coordinate；Seal wire is located at conduit and small intracavitary.The utility model is used to expand in the operation for applying Lai Mushi pipes, the effect that Lai Mushi pipes are applied in expansion can be played for a long time, to reduce intraocular pressure, treat glaucoma, and operation technique is simple, a kind of modus operandi simple to operation is provided to doctor, is conducive to popularization and application.
Description
Technical field
The utility model is related to a kind of operated eye support technology field, especially a kind of to have traction push function
Apply Lai Mushi pipe holders.
Background technology
Glaucoma is a kind of common ophthalmology disease, is to cause one of three big diseases causing blindnesses of mankind's blindness.Glaucoma is led to
Normally due to the dynamic equilibrium of aqueous humor circulation receives destruction, aqueous humor drainage is not smooth, causes intraocular pressure to raise, and lasting Bulbi hypertonia can
To bring infringement to eyeball each several part tissue and visual function, such as treat not in time, the visual field can be arrived with total loss blinds.
Under normal circumstances, aqueous humor is discharged to anterior chamber from back room, by trabecular network, into Lai Mushi pipes are applied, then from applying lime
Family name's pipe is discharged into veins of sclera system and enters blood circulation.Occur narrow or when collapsing when applying Lai Mushi pipes tube chamber, can cause
Aqueous humor drainage obstacle, so that intraocular pressure is raised, triggers glaucoma.
Applying Lai Mushi governances clinically by expansion and treat in the operation of glaucoma mainly includes Viscocanalostomy
（viscocanalostomy）And canaloplasty（canaloplasty）.Viscocanalostomy is by applying Lai Mushi
Viscoelastic agent is injected in pipe and applies the purpose of Lai Mushi pipes to reach expansion, but viscoelastic agent can not long-term existence in lesions position, effect
It is really of short duration, it can not be played a role if being flushed away.Canaloplasty is very high to the technical requirements of doctor, and surgical outcome
Body otherness is big, and reproducibility is poor, and with complication.
Utility model content
The utility model offer is a kind of to apply Lai Mushi pipe holders with traction push function, to solve above-mentioned background technology
The problem of middle proposition.In the operation that Lai Mushi pipes are applied for expanding, to reduce intraocular pressure, glaucoma is treated.One is provided to doctor
Modus operandi simple to operation is planted, is conducive to popularization and application.
The technical problem that the utility model is solved is realized using following technical scheme：The utility model one kind, which has, leads
That draws push function applies Lai Mushi pipe holders, including rack body, the pusher that is connected with rack body, described support sheet
Body is two-chamber tubular structure, and described two-chamber includes big chamber and small chamber, and described big chamber is provided with waist hole, institute with small chamber contact surface
The big chamber upper end stated is provided with the gap for traversing head and the tail, and the two side of described big chamber gap is provided with otch, described small chamber end
Hold end that there is a cone mouth；Described pusher includes conduit, seal wire and injection device, and described conduit includes near-end
Part and distal portions, described proximal part connection injection device, the port of described distal portions is conehead formula opening shape,
The conehead formula opening shape of described distal end of catheter coordinates with small chamber end cone mouth；Described seal wire is located at conduit and small intracavitary.
The longitudinal section of described described rack body is circular or ellipse.
Described waist hole is evenly distributed on the contact surface of big chamber and small chamber.
Described otch is circular arc, rectangle, trapezoidal or kidney ellipsoid.
The described a diameter of 0.1-0.25mm of big chamber, lumen diameter is 0.01-0.15mm, and stent length is 1mm-40mm.
The housing of described rack body be biocompatibility high polymer housing, Stainless Steel Shell, golden shell body, silver-colored housing,
Platinum housing or nickel housing.
Described rack body is provided with biocompatible hydrophilic coating, and described biocompatible hydrophilic coating includes controlling
The property treated medication coat and polymeric coating layer.
Described conduit is flexible and transparent conduit, and described catheter outer diameter is 0.1-0.25mm, and length is 1-200mm.
The a diameter of 0.01-0.10mm of described seal wire, length is 20-100mm.
The beneficial effects of the utility model are：In the operation that Lai Mushi pipes are applied for expanding, expansion can be played for a long time
The effect of Lai Mushi pipes is applied, to reduce intraocular pressure, glaucoma is treated, and operation technique is simple, and reproducibility is strong, sends out disease incidence
It is low, a kind of modus operandi simple to operation is provided to doctor, is conducive to popularization and application, in addition, being traversed on described big chamber
The gap of head and the tail is conducive to the stress release of support, reduces operation risk.
Brief description of the drawings
Fig. 1 is the front view of the utility model structure
Fig. 2 is A partial enlarged drawings in Fig. 1
Fig. 3 is longitudinal sectional view of the present utility model.
Embodiment
The utility model is described further below in conjunction with accompanying drawing：A kind of Lai Mushi that applies with traction push function is managed
Support, including rack body 3, the pusher that is connected with rack body 3, described rack body 3 are two-chamber tubular structure, institute
The two-chamber stated includes big chamber 5 and small chamber 7, and described big chamber 5 is provided with waist hole 6, the described upper end of big chamber 5 with the small contact surface of chamber 7
Provided with the gap 8 for traversing head and the tail, the two side of the described gap 8 of big chamber 5 is provided with otch 4, the described end end of small chamber 7
With a cone mouth；Described pusher includes conduit 2, seal wire 1 and injection device, and described conduit 2 includes proximal part
And distal portions, described proximal part connection injection device, the port of described distal portions is conehead formula opening shape, described
The conehead formula opening shape of the distal end of conduit 2 coordinate with the end cone mouth of small chamber 7；Described seal wire 1 is located in conduit 2 and small chamber 7.
The longitudinal section of described described rack body 3 is circular or ellipse.Described waist hole 6 is evenly distributed on big chamber 5 and small chamber 7
Contact surface on.Described otch 4 is circular arc, rectangle, trapezoidal or kidney ellipsoid.The described a diameter of 0.1-0.25mm of big chamber 5,
The a diameter of 0.01-0.15mm of small chamber 7, stent length is 1mm-40mm.The housing of described rack body 3 is that biocompatibility is high
Polymers housing, Stainless Steel Shell, golden shell body, silver-colored housing, platinum housing or nickel housing.Described rack body 3 is provided with biofacies
Capacitive hydrophilic coating, described biocompatible hydrophilic coating includes curative drug coating and polymeric coating layer.Described leads
Pipe 2 is flexible and transparent conduit 2, and the described external diameter of conduit 2 is 0.1-0.25mm, and length is 1-200mm.The described diameter of seal wire 1
For 0.01-0.10mm, length is 20-100mm.
Described otch 4 is two kinds of circular arc and kidney ellipsoid, using laser cutting.For circular-arc cut 4, adjacent two
Otch 4 is apart from for 0.60mm, and arc radius is 0.23mm.For oval v notch v, oval radius is 0.08mm, oval central moment
For 0.10mm, adjacent two otch 4 is apart from for 0.60mm.Circular arc cutaway and oval v notch v on support do not have stress concentration effect
Should, prevent tear, it is ensured that tension is slight and turns round control stability；There is edge to lead for circular arc cutaway and oval v notch v on support
The inclined-plane of the direction of advance of pipe 2, it is ensured that the transporting of support, prevents implantation process from being damaged to lesions position；The otch 4 of conduit 2
Cut for bilateral, while proof strength, hollow out ratio is provided to greatest extent, is conducive to aqueous humor to discharge.
The gap 8 through body on described rack body 3, the width of gap 8 is 0.05mm.The presence of gap 8 is improved
The elastic deformation ability of support, is conducive to stress release, while improving the hollow out ratio of support, is conducive to the discharge of aqueous humor.
The described length of conduit 2 is 20mm.The remote port of conduit 2 is conehead shape, and the depth of conehead is 0.23mm, conehead
Big footpath is 0.15mm, and the path of conehead is 0.08mm.The conehead of conduit 2 and the cone mouth size of stent ends are adapted, can be by
The conehead of conduit 2 is inserted at the cone mouth of stent ends, and conduit 2 has a push power to support in implantation process, pushes support
Advance.The wherein conehead of conduit 2 is more bigger than the cone mouth taper of stent ends, can so make conduit 2 when support is departed from
Easily, prevent stuck.The conehead leading portion of conduit 2 is non-closed state, is a unlimited hole, the connection injection of the near-end of conduit 2
Device, during stent pushing, viscoelastic agent is injected conduit 2 by injection device, and viscoelastic agent passes through the hole at the distal end conehead of conduit 2
The injection of otch 4 with support is applied in Lai Mushi pipes, is played a part of expansion and is applied Lai Mushi pipes, contributes to the push of support.
The described length 20 of seal wire 1 is 25mm, and the diameter 21 of seal wire 1 is 0.05mm, and seal wire 1 can set bending, and curved
Shape includes being not limited to one kind, and different bendings can be set according to different human eye sizes.In implantation process, support is along seal wire 1
Bending track is pushed into, can preferably meet the flexibility for applying Lai Mushi pipes, it is to avoid the injury to applying Lai Mushi pipes,
Add the torsion control of push.
The process for being implanted into support is as follows：First the distal end conehead of conduit 2 is inserted at the small end cone mouth of chamber 7, complete support and
The assembling of conduit 2, then passes through conduit 2 and support by seal wire 1, completes the assembling of conduit 2, seal wire 1 and support.In implantation process
In, viscoelastic agent is injected into conduit 2 by injection device, viscoelastic agent is entered by the otch 4 of conduit 2 and support applies Lai Mushi pipes
In play a part of expanding it, support is implanted into when beating viscoelastic agent, in whole process, before track of the support along seal wire 1
Enter, seal wire 1 plays a part of guide, conduit 2 plays push in stent ends.After support reaches specified location, by conduit 2
Drawn back with seal wire 1.
Finally illustrate, choose above-described embodiment and it is described in detail and description is to preferably say
The technical scheme of bright patent of the present invention, is not intended to be confined to shown details.Those skilled in the art is to the present invention's
Technical scheme is modified or replaced on an equal basis, without departing from the objective and scope of technical solution of the present invention, all should be covered at this
Among the right of invention.
Claims (9)
1. it is a kind of there is traction push function apply Lai Mushi pipe holders, including rack body, the push that is connected with rack body
Device, it is characterised in that：Described rack body is two-chamber tubular structure, and described two-chamber includes big chamber and small chamber, described
Big chamber and small chamber contact surface are provided with waist hole, and described big chamber upper end is provided with the gap for traversing head and the tail, described big chamber gap
Two side is provided with otch, and described small chamber end end has a cone mouth；Described pusher includes conduit, seal wire
And injection device, described conduit includes proximal part and distal portions, and described proximal part connection injection device is described
The port of distal portions is conehead formula opening shape, and the conehead formula opening shape of described distal end of catheter coordinates with small chamber end cone mouth；
Described seal wire is located at conduit and small intracavitary.
A kind of there is traction push function to apply Lai Mushi pipe holders 2. according to claim 1, it is characterised in that：It is described
The longitudinal section of rack body be circular or ellipse.
A kind of there is traction push function to apply Lai Mushi pipe holders 3. according to claim 1, it is characterised in that：It is described
Waist hole be evenly distributed on the contact surface of big chamber and small chamber.
A kind of there is traction push function to apply Lai Mushi pipe holders 4. according to claim 1, it is characterised in that：It is described
Otch be circular arc, rectangle, trapezoidal or kidney ellipsoid.
A kind of there is traction push function to apply Lai Mushi pipe holders 5. according to claim 1, it is characterised in that：It is described
The a diameter of 0.1-0.25mm of big chamber, lumen diameter is 0.01-0.15mm, and stent length is 1mm-40mm.
A kind of there is traction push function to apply Lai Mushi pipe holders 6. according to claim 1, it is characterised in that：It is described
Rack body housing be biocompatibility high polymer housing, Stainless Steel Shell, golden shell body, silver-colored housing, platinum housing or nickel shell
Body.
A kind of there is traction push function to apply Lai Mushi pipe holders 7. according to claim 1, it is characterised in that：It is described
Rack body be provided with biocompatible hydrophilic coating, described biocompatible hydrophilic coating includes curative drug coating
And polymeric coating layer.
A kind of there is traction push function to apply Lai Mushi pipe holders 8. according to claim 1, it is characterised in that：It is described
Conduit be flexible and transparent conduit, described catheter outer diameter is 0.1-0.25mm, and length is 1-200mm.
A kind of there is traction push function to apply Lai Mushi pipe holders 9. according to claim 1, it is characterised in that：It is described
The a diameter of 0.01-0.10mm of seal wire, length is 20-100mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201621076277.3U CN206424205U (en) | 2016-09-23 | 2016-09-23 | Lai Mushi pipe holders are applied with traction push function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201621076277.3U CN206424205U (en) | 2016-09-23 | 2016-09-23 | Lai Mushi pipe holders are applied with traction push function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN206424205U true CN206424205U (en) | 2017-08-22 |
Family
ID=59588389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201621076277.3U Active CN206424205U (en) | 2016-09-23 | 2016-09-23 | Lai Mushi pipe holders are applied with traction push function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN206424205U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106691683A (en) * | 2016-09-23 | 2017-05-24 | 天津优视眼科技术有限公司 | Schlemm's canal support with traction and pushing functions |
-
2016
- 2016-09-23 CN CN201621076277.3U patent/CN206424205U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106691683A (en) * | 2016-09-23 | 2017-05-24 | 天津优视眼科技术有限公司 | Schlemm's canal support with traction and pushing functions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101522549B1 (en) | Devices and methods for opening fluid passageways | |
| CN107185099B (en) | Catheter special for female | |
| JP5581351B2 (en) | Glaucoma treatment equipment | |
| US7488303B1 (en) | Ocular implant with anchor and multiple openings | |
| JP5328788B2 (en) | Intraocular implant with hydrogel expansion capability | |
| US6966888B2 (en) | Sinus valved glaucoma shunt | |
| JP5524983B2 (en) | Implant system | |
| US9066783B2 (en) | Methods and apparatus for treating glaucoma | |
| CN105056369B (en) | Method and apparatus for being transported to ocular implants in eyes | |
| KR20040036912A (en) | Improved shunt device and method for treating glaucoma | |
| US20080045878A1 (en) | Therapeutic shunt device and method for treating glaucoma | |
| US20060116626A1 (en) | Fluid infusion methods for glaucoma treatment | |
| JP2018534073A (en) | Implantable biocompatible dilator suitable for treatment of luminal strictures | |
| JP2002541976A (en) | Stent device and method for treating glaucoma | |
| JP2007534383A (en) | Indwelling shunt device and device and method for glaucoma | |
| JP2004518450A (en) | Glaucoma treatment apparatus and treatment method | |
| JP2012526637A (en) | Method and apparatus for subretinal catheter insertion | |
| CN108784895A (en) | A kind of expandable stent system | |
| JP5318925B2 (en) | Urinary catheter | |
| CN106691682A (en) | Schlemm tube stand with indication and push function | |
| CN206424205U (en) | Lai Mushi pipe holders are applied with traction push function | |
| CN207821956U (en) | A kind of expandable stent system | |
| CN205434069U (en) | Device and system are implanted in miniature glaucoma drainage | |
| JP2002143318A (en) | Assembly of introducing catheter and catheter for diagnosis and medical treatment | |
| WO2023286638A1 (en) | Catheter and method for operating catheter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231122 Address after: 300300 Tianjin Binhai New Area Tianjin Pilot Free Trade Zone (Airport Economic Zone) West 8th Road No. 9 Factory Building 1 Third Floor West Zone Patentee after: TIANJIN YOUSHI OPHTHALMIC TECHNOLOGY CO.,LTD. Patentee after: BEIJING TIANMING OPHTHALMIC NEW TECHNOLOGY DEVELOPMENT CO. Address before: 300203 Tianjin Binhai New Area pilot free trade zone (Airport Economic Zone) Patentee before: TIANJIN YOUSHI OPHTHALMIC TECHNOLOGY CO.,LTD. Patentee before: BEIJING TONGREN HOSPITAL, CAPITAL MEDICAL University |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240306 Address after: 300000 Tianjin Binhai New Area Free Trade Pilot Zone (Airport Economic Zone) West 8th Road, Building 9, West 3rd Floor, West Zone Patentee after: TIANJIN YOUSHI OPHTHALMIC TECHNOLOGY CO.,LTD. Country or region after: China Address before: 300300 Tianjin Binhai New Area Tianjin Pilot Free Trade Zone (Airport Economic Zone) West 8th Road No. 9 Factory Building 1 Third Floor West Zone Patentee before: TIANJIN YOUSHI OPHTHALMIC TECHNOLOGY CO.,LTD. Country or region before: China Patentee before: BEIJING TIANMING OPHTHALMIC NEW TECHNOLOGY DEVELOPMENT CO. |
|
| TR01 | Transfer of patent right |